MedPath

Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case

Not Applicable
Terminated
Conditions
Liver Biopsy
Interventions
Device: Planning@IFE and Standard@IFE Software
Device: MR Syngo (Numaris/4) software
Registration Number
NCT02573545
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

To demonstrate that the use of Standard @IFE and Planning@IFE features of the IFE software, compared to the current method, when planning and inserting the needle under MRI monitoring in the context of liver biopsies enable:

* a facilitation of the planning stages of the procedure (route path, marking of the entry point and alignment of the MRI cutaways on the planned path), resulting in a reduction in the duration of the planning stages,

* a facilitation of the real-time modification of MRI cutaways during the procedure, resulting in a reduction of the duration of the procedure

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
148
Inclusion Criteria
  • Patient is at least 18 years old
  • Affiliated to a social security scheme
  • Informed consent
  • Patient with an indication of liver biopsy eligible for a biopsy under interventional MRI
Exclusion Criteria
  • Patient with a contraindication for MRI exam
  • Patient with a contraindication for performing a biopsy
  • Pregnancy
  • Exclusion period
  • Patient unable to receive and understand information about the study
  • Patients under guardianship
  • Patients under judicial protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Test group: with IFEPlanning@IFE and Standard@IFE SoftwarePatients treated with IFE software
Test group: without IFEMR Syngo (Numaris/4) softwarePatients treated with Numaris 4 software
Primary Outcome Measures
NameTimeMethod
Total duration of the intervention (planning and implementation)up to 2 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nouvel Hôpital civil

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath